Bank of Montreal
KITE

Bank of Montreal’s Kite Pharma, Inc. KITE Stock Holding History

Bank of Montreal’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-185,421
Closed -$33.3M – 4483
2017
Q3 		$33.3M Buy
185,421
+176,523
+1,984% +$24.6M 0.03% 445
2017
Q2 		$923K Buy
8,898
+1,293
+17% +$106K ﹤0.01% 2016
2017
Q1 		$597K Sell
7,605
-1,657
-18% -$102K ﹤0.01% 2051
2016
Q4 		$472K Buy
9,262
+2,857
+45% +$140K ﹤0.01% 2146
2016
Q3 		$358K Hold
6,405
– – ﹤0.01% 2210
2016
Q2 		$320K Buy
6,405
+6,108
+2,057% +$300K ﹤0.01% 2258
2016
Q1 		$14K Hold
297
– – ﹤0.01% 3522
2015
Q4 		$18K Sell
297
-1,500
-83% -$106K ﹤0.01% 3440
2015
Q3 		$100K Sell
1,797
-20,984
-92% -$1.32M ﹤0.01% 2631
2015
Q2 		$1.39M Sell
22,781
-672
-3% -$38.3K ﹤0.01% 1526
2015
Q1 		$1.35M Buy
23,453
+19,638
+515% +$1.32M ﹤0.01% 1518
2014
Q4 		$220K Buy
3,815
+894
+31% +$37.6K ﹤0.01% 2438
2014
Q3 		$83K Buy
+2,921
New +$72.3K ﹤0.01% 2914

Bank of Montreal's KITE Position: Q4 2017 in Review

Bank of Montreal sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 185,421 shares — an estimated $33.3M sold.

Bank of Montreal first reported a position in KITE in Q3 2014 and held it in 13 quarters. The position peaked at $33.3M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Bank of Montreal reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Bank of Montreal sold 185,421 Kite Pharma, Inc. shares in Q4 2017, an estimated $33.3M.
  • Bank of Montreal first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 13 quarters.
  • Bank of Montreal's Kite Pharma, Inc. position peaked at $33.3M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Bank of Montreal's 13F filing for Q4 2017, filed 16 Jan 2018.